Reno, NV – Klaire Labs (SFI USA) today announced the availability of Clearity, a unique
antioxidant formula designed to support auditory and vestibular function.†
Hearing loss affects 17% of the U.S. population. Approximately half of adults over 65 are
affected, and the figure increases to 83% over the age of seventy.1
In addition to direct effects on the auditory and vestibular systems, age-related hearing
loss is linked to a feeling of isolation, cognitive decline, and mood alterations.2,3
Investigators have also demonstrated that noise and disequilibrium can cause psychological
and physiological stress.4,5 Moreover, many recent studies have shown evidence for hidden
hearing loss and associated effects on speech recognition and mental processing induced by
synaptic changes.6,7
Conceived of and patented by otolaryngologist Ford Albritton IV, MD, the multi-nutrient Clearity
formulation was developed based on published active ingredient efficacy which includes
antioxidants, flavonoids, and phyto- and micro-nutrients. Outcomes performance has been
further demonstrated by more than two decades of clinical use assessed by audiometry and
other quantitative and qualitative measures.
“In an aging population, hearing support becomes an important priority for maintaining cognitive
health and quality of life,” states Dr. Leah Linder, ND—Klaire Labs’ Science & Education
Manager. “The evidence-based Clearity formulation offers a promising preventative measure for
hearing and oxidative stress overall.”
Formulated to Dr. Albritton’s exacting specifications, Klaire Labs’ Clearity offers a unique blend
of the highest quality and extensively studied nutrients to support sensorineural function.†
About Klaire Labs
Klaire Labs has been formulating and manufacturing premium, hypoallergenic supplements sold
through healthcare practitioners for nearly half a century. Our mission is to develop and
manufacture the purest, most potent nutraceuticals possible, thereby empowering clinicians with
consistently reliable performance.
References:
1. (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4811604/)
2. Audiol Neurotol. 2007;12:345-358
3. Sci Rep. 2018;8(1):15266
4. Arch Intern Med. 2011;171(20):1851-2
5. Hear Res. 2009;264(1-2):98-107
6. Audiol Neurotol. 2016;21(suppl 1):21–28
7. Sci Rep. 2018;8(1):15266
† These statements have not been evaluated by the Food and Drug Administration. These
products are not intended to diagnose, treat, cure, or prevent any disease.
